Soleno Therapeutics Financials

SLNO Stock  USD 49.84  0.48  0.97%   
Based on the key indicators related to Soleno Therapeutics' liquidity, profitability, solvency, and operating efficiency, Soleno Therapeutics is not in a good financial situation at this time. It has a very high probability of going through financial hardship in March.
  

Soleno Therapeutics Stock Summary

Soleno Therapeutics competes with Annexon, Bolt Biotherapeutics, Lyra Therapeutics, Pulmatrix, and Capricor Therapeutics. Soleno Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Soleno Therapeutics, Inc. was incorporated in 1999 and is based in Redwood City, California. Soleno Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 20 people.
Specialization
Healthcare, Biotechnology
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS8342032005
CUSIP834203309 834203200 14066L105 834203101
LocationCalifornia; U.S.A
Business Address203 Redwood Shores
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitesoleno.life
Phone650 213 8444
CurrencyUSD - US Dollar

Soleno Therapeutics Key Financial Ratios

Soleno Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Soleno Therapeutics's current stock value. Our valuation model uses many indicators to compare Soleno Therapeutics value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Soleno Therapeutics competition to find correlations between indicators driving Soleno Therapeutics's intrinsic value. More Info.
Soleno Therapeutics is rated below average in return on equity category among its peers. It is rated below average in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Soleno Therapeutics' earnings, one of the primary drivers of an investment's value.

Soleno Therapeutics Systematic Risk

Soleno Therapeutics' systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Soleno Therapeutics volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was twenty-four with a total number of output elements of thirty-seven. The Beta measures systematic risk based on how returns on Soleno Therapeutics correlated with the market. If Beta is less than 0 Soleno Therapeutics generally moves in the opposite direction as compared to the market. If Soleno Therapeutics Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Soleno Therapeutics is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Soleno Therapeutics is generally in the same direction as the market. If Beta > 1 Soleno Therapeutics moves generally in the same direction as, but more than the movement of the benchmark.

Soleno Therapeutics January 31, 2025 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of Soleno Therapeutics help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Soleno Therapeutics. We use our internally-developed statistical techniques to arrive at the intrinsic value of Soleno Therapeutics based on widely used predictive technical indicators. In general, we focus on analyzing Soleno Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Soleno Therapeutics's daily price indicators and compare them against related drivers.
When determining whether Soleno Therapeutics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Soleno Therapeutics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Soleno Therapeutics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Soleno Therapeutics Stock:
Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Soleno Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices.
To learn how to invest in Soleno Stock, please use our How to Invest in Soleno Therapeutics guide.
You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Soleno Therapeutics. If investors know Soleno will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Soleno Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Soleno Therapeutics is measured differently than its book value, which is the value of Soleno that is recorded on the company's balance sheet. Investors also form their own opinion of Soleno Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Soleno Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Soleno Therapeutics' market value can be influenced by many factors that don't directly affect Soleno Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Soleno Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Soleno Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Soleno Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.